AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Armata Pharmaceuticals, Inc. Director's Dealing 2016

Jan 20, 2016

34152_dirs_2016-01-20_a9fe6b68-745c-408a-98bf-f7f9777a0b15.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AmpliPhi Biosciences Corp (APHB)
CIK: 0000921114
Period of Report: 2016-01-18

Reporting Person: Martin Steven Robert (Chief Financial Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	0	Direct